SCHEMBL3273480

SCHEMBL3273480

Nc1nc(-c2ccco2)c2ncn(C(=O)NC3CCCCC3)c2n1

nearest known ligand 0.66

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 20/20 0.66
ADORA1 P30542 19/20 0.66
ADORA3 P0DMS8 3/20 0.64
ADORA2B P29275 3/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3274897 0.88 ADORA2A (0.51) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL3274495 0.85 ADORA2A (0.61) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL3272428 0.82 ADORA2A (0.80) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL3270277 0.81 ADORA2A (0.76) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL3267549 0.80 ADORA2A (0.78) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL3269076 0.80 ADORA2A (0.71) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL3277224 0.80 ADORA2A (1.00) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL3272472 0.79 ADORA2A (0.69) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL3270103 0.79 HDAC6 (0.41) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL3269231 0.79 ADORA2A (0.63) ADORA2AADORA1ADORA3ADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1349857-B1 PURINE DERIVATIVES AS PURINERGIC RECEPTOR ANTAGONISTS VERNALIS RES LTD (GB) 2010-06-16 EP disclosed
US-7452894-B2 Purine derivatives as purinergic receptor antagonists VERNALIS RESEARCH LIMITED (GB) 2008-11-18 US disclosed
US-7452894-B2 Purine derivatives as purinergic receptor antagonists VERNALIS RESEARCH LIMITED (GB) 2008-11-18 US disclosed
US-7452894-B2 Purine derivatives as purinergic receptor antagonists VERNALIS RESEARCH LIMITED (GB) 2008-11-18 US disclosed